Asian Journal of Pharmaceutical Research
  • Year: 2025
  • Volume: 15
  • Issue: 3

Understanding Cystic Fibrosis: Causes, Symptoms, and Treatment Strategies

  • Author:
  • N Urvashi Patil1,*, R Sameer Shaikh1, R Divakar Patil1, S Akash Jain1, Z Azam Shaikh2,**
  • Total Page Count: 6
  • Published Online: Nov 19, 2025
  • Page Number: 347 to 352

1Bachelor of Pharmacy, P.S.G.V.P. M’s College of Pharmacy, Shahada

2Assistant Professor, Department of Pharmaceutics, P.S.G.V.P. M’s College of Pharmacy, Shahada, Maharashtra, India

*Corresponding Author Email: patilurvashi778@gmail.com

**azamph46@gmail.com

Online published on 19 November, 2025.

Abstract

Cystic fibrosis (CF) develop multilobular cirrhosis. Later on, the majority of CF patients experience problems from portal hypertension, primarily varicealhemorrhage. Liver failure typically strikes later in life, following childhood. It is advised to screen for liver disease every year in order to identify any presymptomatic indicators and to start ursodeoxycholic acid therapy, which may slow the illness’s course. If two or more of the following criteria are met: abnormal physical examination, consistently abnormal liver function tests, and pathological ultrasonography, liver disease should be suspected. A liver biopsy is necessary if the diagnosis is unclear. Annual follow-up is necessary for all CF patients with liver disease to assess the onset of cirrhosis, portal hypertension, or liver failure. The goals of management should be on nutrition, hemorrhage control, andvariceal disintegration. When considering liver transplantation, deterioration of pulmonary function is crucial, especially in adolescents with severe portal hypertension or hepatic dysfunction. A hereditary disorder that impacts a protein in the body is known as cystic fibrosis (CF). A defective protein that affects the body’s tissues, glands that produce sweat and mucus, and cells is what causes cystic fibrosis.

Keywords

Cystic Fibrosis, Primarily Variceal Hemorrhage, Etc